Zynex ROIC
What is the ROIC of Zynex?
The ROIC of Zynex, Inc. is 16.72%
What is the definition of ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC of companies in the Health Care sector on XETRA compared to Zynex
What does Zynex do?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Companies with roic similar to Zynex
- R Systems International has ROIC of 16.67%
- Irish Continental plc has ROIC of 16.67%
- Zoetis has ROIC of 16.71%
- Zoetis Cl.A Dl ,01 has ROIC of 16.71%
- Usana Health Sciences Inc has ROIC of 16.71%
- Doximity has ROIC of 16.71%
- Zynex has ROIC of 16.72%
- Ebixcash World Money India has ROIC of 16.73%
- Tractor Supply Co has ROIC of 16.73%
- Bigbloc Construction has ROIC of 16.73%
- EVS Broadcast Equipment SA has ROIC of 16.74%
- EVS Broadcast Equipment S.A has ROIC of 16.74%
- Majestic Research Services and Solutions has ROIC of 16.76%